These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat. Hernandez LE; Jadoo A; Kirsner RS Lancet; 2022 Sep; 400(10355):e8. PubMed ID: 36088950 [No Abstract] [Full Text] [Related]
23. Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox. Suzuki T; Saito S; Tsuzuki S; Ashida S; Takakusaki M; Yoshikawa T; Shimojima M; Ebihara H; Ohmagari N; Morioka S BMJ Open; 2023 Aug; 13(8):e069550. PubMed ID: 37527886 [TBL] [Abstract][Full Text] [Related]
24. Tecovirimat: First Global Approval. Hoy SM Drugs; 2018 Sep; 78(13):1377-1382. PubMed ID: 30120738 [TBL] [Abstract][Full Text] [Related]
25. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Russo AT; Grosenbach DW; Chinsangaram J; Honeychurch KM; Long PG; Lovejoy C; Maiti B; Meara I; Hruby DE Expert Rev Anti Infect Ther; 2021 Mar; 19(3):331-344. PubMed ID: 32882158 [TBL] [Abstract][Full Text] [Related]
26. Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox. Chan-Tack KM; Harrington PR; Choi SY; Myers L; O'Rear J; Seo S; McMillan D; Ghantous H; Birnkrant D; Sherwat AI Lancet Infect Dis; 2019 Jun; 19(6):e221-e224. PubMed ID: 30853252 [TBL] [Abstract][Full Text] [Related]
27. In vitro efficacy of ST246 against smallpox and monkeypox. Smith SK; Olson VA; Karem KL; Jordan R; Hruby DE; Damon IK Antimicrob Agents Chemother; 2009 Mar; 53(3):1007-12. PubMed ID: 19075062 [TBL] [Abstract][Full Text] [Related]
28. Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection. Desai AN; Thompson GR; Neumeister SM; Arutyunova AM; Trigg K; Cohen SH JAMA; 2022 Oct; 328(13):1348-1350. PubMed ID: 35994281 [TBL] [Abstract][Full Text] [Related]
29. The development and approval of tecoviromat (TPOXX Merchlinsky M; Albright A; Olson V; Schiltz H; Merkeley T; Hughes C; Petersen B; Challberg M Antiviral Res; 2019 Aug; 168():168-174. PubMed ID: 31181284 [TBL] [Abstract][Full Text] [Related]
30. ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation. Berhanu A; King DS; Mosier S; Jordan R; Jones KF; Hruby DE; Grosenbach DW Antimicrob Agents Chemother; 2009 Dec; 53(12):4999-5009. PubMed ID: 19752270 [TBL] [Abstract][Full Text] [Related]
31. Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies. Sudarmaji N; Kifli N; Hermansyah A; Yeoh SF; Goh BH; Ming LC Viruses; 2022 Nov; 14(11):. PubMed ID: 36423105 [TBL] [Abstract][Full Text] [Related]
32. Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus. Smith SK; Self J; Weiss S; Carroll D; Braden Z; Regnery RL; Davidson W; Jordan R; Hruby DE; Damon IK J Virol; 2011 Sep; 85(17):9176-87. PubMed ID: 21697474 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects. Das T; Nandy S; Ghosh A; Chandran D; Sharma AK; Dhama K; Dey A Int J Surg; 2023 May; 109(5):1528-1530. PubMed ID: 36974695 [No Abstract] [Full Text] [Related]
35. A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge. Parker S; D'Angelo J; Buller RM; Smee DF; Lantto J; Nielsen H; Jensen A; Prichard M; George SL Antiviral Res; 2021 Nov; 195():105179. PubMed ID: 34530009 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection. Sbrana E; Jordan R; Hruby DE; Mateo RI; Xiao SY; Siirin M; Newman PC; DA Rosa AP; Tesh RB Am J Trop Med Hyg; 2007 Apr; 76(4):768-73. PubMed ID: 17426185 [TBL] [Abstract][Full Text] [Related]
37. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review. Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502 [TBL] [Abstract][Full Text] [Related]
38. Monkeypox in Patient Immunized with ACAM2000 Smallpox Vaccine During 2022 Outbreak. Turner M; Mandia J; Keltner C; Haynes R; Faestel P; Mease L Emerg Infect Dis; 2022 Nov; 28(11):2336-2338. PubMed ID: 36104166 [TBL] [Abstract][Full Text] [Related]